Username

Password

Forgot Password?

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Stephen Straus

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Living Beings

Disorders

Chemicals & Drugs

Physiology

Virus Latency

Anatomy

Phenomena

Recurrence

Sign-in to see full Profile

Network (preview)

Co-Publications
Name
30
Dale, Janet
24
Puck, Jennifer
19
Pesnicak, Lesley
17
Lenardo, Michael
16
Fleisher, Thomas
15
Cohen, Jeffrey
9
sneller, michael
7
Bleesing, Jack
6
Siegel, Richard
6
Wang, Juehu
6
Wang, Kening
6
Moriuchi, H
6
Moriuchi, M
6
Rao, Koneti
5
Kost, Rhonda

Sign-in to see all Coauthors

Publications

TOP 3
Hoshino Yo; Pesnicak Lesley; Dowdell Kennichi C; Burbelo Peter D; Knipe David M; Straus Stephen E; Cohen Jeffrey I
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
Hoshino Yo; Pesnicak Lesley; Straus Stephen E; Cohen Jeffrey I
Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia.
Dowdell Kennichi C; Pesnicak Lesley; Hoffmann Victoria; Steadman Kenneth; Remaley Alan T; Cohen Jeffrey I; Straus Stephen E; Rao V Koneti
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Stephen Straus (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Hoshino Yo; Pesnicak Lesley; Dowdell Kennichi C; Burbelo Peter D; Knipe David M; Straus Stephen E; Cohen Jeffrey I
Protection from herpes simplex virus (HSV)-2 infection with replication-defective HSV-2 or glycoprotein D2 vaccines in HSV-1-seropositive and HSV-1-seronegative guinea pigs.
The Journal of infectious diseases 2009;200(7):1088-95.
2009: Hoshino Yo; Pesnicak Lesley; Straus Stephen E; Cohen Jeffrey I
Impairment in reactivation of a latency associated transcript (LAT)-deficient HSV-2 is not solely dependent on the latent viral load or the number of CD8(+) T cells infiltrating the ganglia.
Virology 2009;387(1):193-9.
2009: Dowdell Kennichi C; Pesnicak Lesley; Hoffmann Victoria; Steadman Kenneth; Remaley Alan T; Cohen Jeffrey I; Straus Stephen E; Rao V Koneti
Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr(-/-) murine model of autoimmune lymphoproliferative syndrome (ALPS).
Experimental hematology 2009;37(4):487-94.
2009: Wang Kening; Mahalingam Gowtham; Imai Yumi; Pesnicak Lesley; Margolis Todd P; Straus Stephen E; Cohen Jeffrey I
Cell type specific accumulation of the major latency-associated transcript (LAT) of herpes simplex virus type 2 in LAT transgenic mice.
Virology 2009;386(1):79-87.
2008: Hoshino Yo; Pesnicak Lesley; Dowdell Kennichi C; Lacayo Juan; Dudek Timothy; Knipe David M; Straus Stephen E; Cohen Jeffrey I
Comparison of immunogenicity and protective efficacy of genital herpes vaccine candidates herpes simplex virus 2 dl5-29 and dl5-29-41L in mice and guinea pigs.
Vaccine 2008;26(32):4034-40.
2008: Hadi Mohiuddin; Bacharach Stephen L; Whatley Millie; Libutti Steven K; Straus Stephen E; Rao V Koneti; Wesley Robert; Carrasquillo Jorge A
Glucose and insulin variations in patients during the time course of a FDG-PET study and implications for the "glucose-corrected" SUV.
Nuclear medicine and biology 2008;35(4):441-5.
2008: Hoshino Yo; Qin Jing; Follmann Dean; Cohen Jeffrey I; Straus Stephen E
The number of herpes simplex virus-infected neurons and the number of viral genome copies per neuron correlate with the latent viral load in ganglia.
Virology 2008;372(1):56-63.
2007: Rao V Koneti; Dowdell Kennichi C; Dale Janet K; Dugan Faith; Pesnicak Lesley; Bi Lilia L; Hoffmann Victoria; Penzak Scott; Avila Nilo A; Fleisher Thomas A; Puck Jennifer M; Straus Stephen E
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
American journal of hematology 2007;82(12):1049-55.
2007: Hoshino Yo; Pesnicak Lesley; Cohen Jeffrey I; Straus Stephen E
Rates of reactivation of latent herpes simplex virus from mouse trigeminal ganglia ex vivo correlate directly with viral load and inversely with number of infiltrating CD8+ T cells.
Journal of virology 2007;81(15):8157-64.
2007: Wang Kening; Mahalingam Gowtham; Hoover Susan E; Mont Erik K; Holland Steven M; Cohen Jeffrey I; Straus Stephen E
Diverse herpes simplex virus type 1 thymidine kinase mutants in individual human neurons and Ganglia.
Journal of virology 2007;81(13):6817-26.
2007: Oliveira João B; Bidère Nicolas; Niemela Julie E; Zheng Lixin; Sakai Keiko; Nix Cynthia P; Danner Robert L; Barb Jennifer; Munson Peter J; Puck Jennifer M; Dale Janet; Straus Stephen E; Fleisher Thomas A; Lenardo Michael J
NRAS mutation causes a human autoimmune lymphoproliferative syndrome.
Proceedings of the National Academy of Sciences of the United States of America 2007;104(21):8953-8.
2007: Bi Lilia L; Pan George; Atkinson T Prescott; Zheng Lixin; Dale Janet K; Makris Christopher; Reddy Vishnu; McDonald Jay M; Siegel Richard M; Puck Jennifer M; Lenardo Michael J; Straus Stephen E
Dominant inhibition of Fas ligand-mediated apoptosis due to a heterozygous mutation associated with autoimmune lymphoproliferative syndrome (ALPS) Type Ib.
BMC medical genetics 2007;8():41.
2006: Zhu Shigui; Hsu Amy P; Vacek Marla M; Zheng Lixin; Schäffer Alejandro A; Dale Janet K; Davis Joie; Fischer Roxanne E; Straus Stephen E; Boruchov Donna; Saulsbury Frank T; Lenardo Michael J; Puck Jennifer M
Genetic alterations in caspase-10 may be causative or protective in autoimmune lymphoproliferative syndrome.
Human genetics 2006;119(3):284-94.
2006: Rao V Koneti; Straus Stephen E
Causes and consequences of the autoimmune lymphoproliferative syndrome.
Hematology (Amsterdam, Netherlands) 2006;11(1):15-23.
2006: Rao V Koneti; Carrasquillo Jorge A; Dale Janet K; Bacharach Stephen L; Whatley Millie; Dugan Faith; Tretler Jean; Fleisher Thomas; Puck Jennifer M; Wilson Wyndham; Jaffe Elaine S; Avila Nilo; Chen Clara C; Straus Stephen E
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).
American journal of hematology 2006;81(2):81-5.
2006: Vacek Marla M; Schäffer Alejandro A; Davis Joie; Fischer Roxanne E; Dale Janet K; Adams Sharon; Straus Stephen E; Puck Jennifer M
HLA B44 is associated with decreased severity of autoimmune lymphoproliferative syndrome in patients with CD95 defects (ALPS type Ia).
Clinical immunology (Orlando, Fla.) 2006;118(1):59-65.
2005: Wang Kening; Lau Tsz Y; Morales Melissa; Mont Erik K; Straus Stephen E
Laser-capture microdissection: refining estimates of the quantity and distribution of latent herpes simplex virus 1 and varicella-zoster virus DNA in human trigeminal Ganglia at the single-cell level.
Journal of virology 2005;79(22):14079-87.
2005: Maric Irina; Pittaluga Stefania; Dale Janet K; Niemela Julie E; Delsol Georges; Diment Judith; Rosai Juan; Raffeld Mark; Puck Jennifer M; Straus Stephen E; Jaffe Elaine S
Histologic features of sinus histiocytosis with massive lymphadenopathy in patients with autoimmune lymphoproliferative syndrome.
The American journal of surgical pathology 2005;29(7):903-11.
2005: Nicola Anthony V; Hou Jean; Major Eugene O; Straus Stephen E
Herpes simplex virus type 1 enters human epidermal keratinocytes, but not neurons, via a pH-dependent endocytic pathway.
Journal of virology 2005;79(12):7609-16.
2005: Rao V Koneti; Dugan Faith; Dale Janet K; Davis Joie; Tretler Jean; Hurley John K; Fleisher Thomas; Puck Jennifer; Straus Stephen E
Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
British journal of haematology 2005;129(4):534-8.
2005: Hoshino Yo; Dalai Sarat K; Wang Kening; Pesnicak Lesley; Lau Tsz Y; Knipe David M; Cohen Jeffrey I; Straus Stephen E
Comparative efficacy and immunogenicity of replication-defective, recombinant glycoprotein, and DNA vaccines for herpes simplex virus 2 infections in mice and guinea pigs.
Journal of virology 2005;79(1):410-8.
2004: Siegel Richard M; Muppidi Jagan R; Sarker Malabika; Lobito Adrian; Jen Melinda; Martin David; Straus Stephen E; Lenardo Michael J
SPOTS: signaling protein oligomeric transduction structures are early mediators of death receptor-induced apoptosis at the plasma membrane.
The Journal of cell biology 2004;167(4):735-44.
2004: Puck Jennifer M; Straus Stephen E
Somatic mutations--not just for cancer anymore.
The New England journal of medicine 2004;351(14):1388-90.
2004: Miller Franklin G; Emanuel Ezekiel J; Rosenstein Donald L; Straus Stephen E
Ethical issues concerning research in complementary and alternative medicine.
JAMA : the journal of the American Medical Association 2004;291(5):599-604.
2004: Katano Harutaka; Ali Mir A; Patera Andriani C; Catalfamo Marta; Jaffe Elaine S; Kimura Hiroshi; Dale Janet K; Straus Stephen E; Cohen Jeffrey I
Chronic active Epstein-Barr virus infection associated with mutations in perforin that impair its maturation.
Blood 2004;103(4):1244-52.
2003: Kwon S-W; Procter J; Dale J K; Straus S E; Stroncek D F
Neutrophil and platelet antibodies in autoimmune lymphoproliferative syndrome.
Vox sanguinis 2003;85(4):307-12.
2003: Nicola Anthony V; McEvoy Anna M; Straus Stephen E
Roles for endocytosis and low pH in herpes simplex virus entry into HeLa and Chinese hamster ovary cells.
Journal of virology 2003;77(9):5324-32.
2003: Xia Dongxiang; Srinivas Shamala; Sato Hitoshi; Pesnicak Lesley; Straus Stephen E; Cohen Jeffrey I
Varicella-zoster virus open reading frame 21, which is expressed during latency, is essential for virus replication but dispensable for establishment of latency.
Journal of virology 2003;77(2):1211-8.
2002: Chun Hyung J; Zheng Lixin; Ahmad Manzoor; Wang Jin; Speirs Christina K; Siegel Richard M; Dale Janet K; Puck Jennifer; Davis Joie; Hall Craig G; Skoda-Smith Suzanne; Atkinson T Prescott; Straus Stephen E; Lenardo Michael J
Pleiotropic defects in lymphocyte activation caused by caspase-8 mutations lead to human immunodeficiency.
Nature 2002;419(6905):395-9.
2002: Bleesing Jack J H; Brown Margaret R; Novicio Cynthia; Guarraia David; Dale Janet K; Straus Stephen E; Fleisher Thomas A
A composite picture of TcR alpha/beta(+) CD4(-)CD8(-) T Cells (alpha/beta-DNTCs) in humans with autoimmune lymphoproliferative syndrome.
Clinical immunology (Orlando, Fla.) 2002;104(1):21-30.
2002: Dalai Sarat K; Pesnicak Lesley; Miller Georgina F; Straus Stephen E
Prophylactic and therapeutic effects of human immunoglobulin on the pathobiology of HSV-1 infection, latency, and reactivation in mice.
Journal of neurovirology 2002;8(1):35-44.
2001: Fleisher T A; Straus S E; Bleesing J J
A genetic disorder of lymphocyte apoptosis involving the fas pathway: the autoimmune lymphoproliferative syndrome.
Current allergy and asthma reports 2001;1(6):534-40.
2001: Bleesing J J; Brown M R; Straus S E; Dale J K; Siegel R M; Johnson M; Lenardo M J; Puck J M; Fleisher T A
Immunophenotypic profiles in families with autoimmune lymphoproliferative syndrome.
Blood 2001;98(8):2466-73.
2001: Bleesing J J; Brown M R; Dale J K; Straus S E; Lenardo M J; Puck J M; Atkinson T P; Fleisher T A
TcR-alpha/beta(+) CD4(-)CD8(-) T cells in humans with the autoimmune lymphoproliferative syndrome express a novel CD45 isoform that is analogous to murine B220 and represents a marker of altered O-glycan biosynthesis.
Clinical immunology (Orlando, Fla.) 2001;100(3):314-24.
2001: Wang K; Pesnicak L; Guancial E; Krause P R; Straus S E
The 2.2-kilobase latency-associated transcript of herpes simplex virus type 2 does not modulate viral replication, reactivation, or establishment of latency in transgenic mice.
Journal of virology 2001;75(17):8166-72.
2001: Straus S E; Jaffe E S; Puck J M; Dale J K; Elkon K B; Rösen-Wolff A; Peters A M; Sneller M C; Hallahan C W; Wang J; Fischer R E; Jackson C M; Lin A Y; Bäumler C; Siegert E; Marx A; Vaishnaw A K; Grodzicky T; Fleisher T A; Lenardo M J
The development of lymphomas in families with autoimmune lymphoproliferative syndrome with germline Fas mutations and defective lymphocyte apoptosis.
Blood 2001;98(1):194-200.
2001: Lopatin U; Yao X; Williams R K; Bleesing J J; Dale J K; Wong D; Teruya-Feldstein J; Fritz S; Morrow M R; Fuss I; Sneller M C; Raffeld M; Fleisher T A; Puck J M; Strober W; Jaffe E S; Straus S E
Increases in circulating and lymphoid tissue interleukin-10 in autoimmune lymphoproliferative syndrome are associated with disease expression.
Blood 2001;97(10):3161-70.
2001: Fleisher T A; Puck J M; Strober W; Dale J K; Lenardo M J; Siegel R M; Straus S E; Bleesing J J
The autoimmune lymphoproliferative syndrome. A disorder of human lymphocyte apoptosis.
Clinical reviews in allergy & immunology 2001;20(1):109-20.
2001: Stroncek D F; Carter L B; Procter J L; Dale J K; Straus S E
RBC autoantibodies in autoimmune lymphoproliferative syndrome.
Transfusion 2001;41(1):18-23.
2001: Straus S E
Varicella-zoster virus immunity and prevention: a conference perspective.
Archives of virology. Supplementum 2001;(17):173-8.
2000: Bleesing J J; Straus S E; Fleisher T A
Autoimmune lymphoproliferative syndrome. A human disorder of abnormal lymphocyte survival.
Pediatric clinics of North America 2000;47(6):1291-310.
2000: Moriuchi M; Moriuchi H; Williams R; Straus S E
Herpes simplex virus infection induces replication of human immunodeficiency virus type 1.
Virology 2000;278(2):534-40.
2000: McKenzie R; Reynolds J C; O'Fallon A; Dale J; Deloria M; Blackwelder W; Straus S E
Decreased bone mineral density during low dose glucocorticoid administration in a randomized, placebo controlled trial.
The Journal of rheumatology 2000;27(9):2222-6.
2000: Carter L B; Procter J L; Dale J K; Straus S E; Cantilena C C
Description of serologic features in autoimmune lymphoproliferative syndrome.
Transfusion 2000;40(8):943-8.
2000: Lekstrom-Himes J A; LeBlanc R A; Pesnicak L; Godleski M; Straus S E
Gamma interferon impedes the establishment of herpes simplex virus type 1 latent infection but has no impact on its maintenance or reactivation in mice.
Journal of virology 2000;74(14):6680-3.
2000: Fang B S; Sneller M C; Straus S E; Frenkel L; Dale J K; Rick M E
Report of a factor VIII inhibitor in a patient with autoimmune lymphoproliferative syndrome.
American journal of hematology 2000;64(3):214-7.
2000: Marques A R; Straus S E
Herpes simplex type 2 infections--an update.
Advances in internal medicine 2000;45():175-208.
1999: Pevenstein S R; Williams R K; McChesney D; Mont E K; Smialek J E; Straus S E
Quantitation of latent varicella-zoster virus and herpes simplex virus genomes in human trigeminal ganglia.
Journal of virology 1999;73(12):10514-8.
1999: Langenberg A G; Corey L; Ashley R L; Leong W P; Straus S E
A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group.
The New England journal of medicine 1999;341(19):1432-8.
1999: LeBlanc R A; Pesnicak L; Cabral E S; Godleski M; Straus S E
Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice.
Journal of virology 1999;73(10):8145-51.
1999: LeBlanc R A; Pesnicak L; Godleski M; Straus S E
Treatment of HSV-1 infection with immunoglobulin or acyclovir: comparison of their effects on viral spread, latency, and reactivation.
Virology 1999;262(1):230-6.
1999: LeBlanc R A; Pesnicak L; Godleski M; Straus S E
The comparative effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice.
The Journal of infectious diseases 1999;180(3):594-9.
1999: Corey L; Langenberg A G; Ashley R; Sekulovich R E; Izu A E; Douglas J M; Handsfield H H; Warren T; Marr L; Tyring S; DiCarlo R; Adimora A A; Leone P; Dekker C L; Burke R L; Leong W P; Straus S E
Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.
JAMA : the journal of the American Medical Association 1999;282(4):331-40.
1999: Wang J; Zheng L; Lobito A; Chan F K; Dale J; Sneller M; Yao X; Puck J M; Straus S E; Lenardo M J
Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
Cell 1999;98(1):47-58.
1999: Avila N A; Dwyer A J; Dale J K; Lopatin U A; Sneller M C; Jaffe E S; Puck J M; Straus S E
Autoimmune lymphoproliferative syndrome: a syndrome associated with inherited genetic defects that impair lymphocytic apoptosis--CT and US features.
Radiology 1999;212(1):257-63.
1999: Cohen J I; Brunell P A; Straus S E; Krause P R
Recent advances in varicella-zoster virus infection.
Annals of internal medicine 1999;130(11):922-32.
1999: Xia D; Straus S E
Transcript mapping and transregulatory behavior of varicella-zoster virus gene 21, a latency-associated gene.
Virology 1999;258(2):304-13.
1999: Lekstrom-Himes J A; Hohman P; Warren T; Wald A; Nam J M; Simonis T; Corey L; Straus S E
Association of major histocompatibility complex determinants with the development of symptomatic and asymptomatic genital herpes simplex virus type 2 infections.
The Journal of infectious diseases 1999;179(5):1077-85.
1999: Martin D A; Zheng L; Siegel R M; Huang B; Fisher G H; Wang J; Jackson C E; Puck J M; Dale J; Straus S E; Peter M E; Krammer P H; Fesik S; Lenardo M J
Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.
Proceedings of the National Academy of Sciences of the United States of America 1999;96(8):4552-7.
1999: Straus S E; Sneller M; Lenardo M J; Puck J M; Strober W
An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome.
Annals of internal medicine 1999;130(7):591-601.
1999: Jackson C E; Fischer R E; Hsu A P; Anderson S M; Choi Y; Wang J; Dale J K; Fleisher T A; Middelton L A; Sneller M C; Lenardo M J; Straus S E; Puck J M
Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance.
American journal of human genetics 1999;64(4):1002-14.
1999: Straus S E
Bridging the gulf in war syndromes.
Lancet 1999;353(9148):162-3.
1998: Kimura H; Straus S E; Williams R K
Baculovirus expression, purification, and properties of varicella-zoster virus gE, gI, and the complex they form.
The Journal of infectious diseases 1998;178 Suppl 1():S13-5.
1998: Infante A J; Britton H A; DeNapoli T; Middelton L A; Lenardo M J; Jackson C E; Wang J; Fleisher T; Straus S E; Puck J M
The clinical spectrum in a large kindred with autoimmune lymphoproliferative syndrome caused by a Fas mutation that impairs lymphocyte apoptosis.
The Journal of pediatrics 1998;133(5):629-33.
1998: Lim M S; Straus S E; Dale J K; Fleisher T A; Stetler-Stevenson M; Strober W; Sneller M C; Puck J M; Lenardo M J; Elenitoba-Johnson K S; Lin A Y; Raffeld M; Jaffe E S
Pathological findings in human autoimmune lymphoproliferative syndrome.
The American journal of pathology 1998;153(5):1541-50.
1998: Marques A R; Lau D T; McKenzie R; Straus S E; Hoofnagle J H
Combination therapy with famciclovir and interferon-alpha for the treatment of chronic hepatitis B.
The Journal of infectious diseases 1998;178(5):1483-7.
1998: McKenzie R; O'Fallon A; Dale J; Demitrack M; Sharma G; Deloria M; Garcia-Borreguero D; Blackwelder W; Straus S E
Low-dose hydrocortisone for treatment of chronic fatigue syndrome: a randomized controlled trial.
JAMA : the journal of the American Medical Association 1998;280(12):1061-6.
1998: Kimura H; Wang Y; Pesnicak L; Cohen J I; Hooks J J; Straus S E; Williams R K
Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis.
The Journal of infectious diseases 1998;178(2):310-7.
1998: Lekstrom-Himes J A; Pesnicak L; Straus S E
The quantity of latent viral DNA correlates with the relative rates at which herpes simplex virus types 1 and 2 cause recurrent genital herpes outbreaks.
Journal of virology 1998;72(4):2760-4.
1998: Lekstrom-Himes J A; Wang K; Pesnicak L; Krause P R; Straus S E
The comparative biology of latent herpes simplex virus type 1 and type 2 infections: latency-associated transcript promoter activity and expression in vitro and in infected mice.
Journal of neurovirology 1998;4(1):27-37.
1998: Cohen J I; Wang Y; Nussenblatt R; Straus S E; Hooks J J
Chronic uveitis in guinea pigs infected with varicella-zoster virus expressing Escherichia coli beta-galactosidase.
The Journal of infectious diseases 1998;177(2):293-300.
1997: Straus S E; Wald A; Kost R G; McKenzie R; Langenberg A G; Hohman P; Lekstrom J; Cox E; Nakamura M; Sekulovich R; Izu A; Dekker C; Corey L
Immunotherapy of recurrent genital herpes with recombinant herpes simplex virus type 2 glycoproteins D and B: results of a placebo-controlled vaccine trial.
The Journal of infectious diseases 1997;176(5):1129-34.
1997: Lakein D A; Fantie B D; Grafman J; Ross S; O'Fallon A; Dale J; Straus S E
Patients with chronic fatigue syndrome and accurate feeling-of-knowing judgments.
Journal of clinical psychology 1997;53(7):635-45.
1997: Wang K; Pesnicak L; Straus S E
Mutations in the 5' end of the herpes simplex virus type 2 latency-associated transcript (LAT) promoter affect LAT expression in vivo but not the rate of spontaneous reactivation of genital herpes.
Journal of virology 1997;71(10):7903-10.
1997: Kimura H; Straus S E; Williams R K
Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I.
Virology 1997;233(2):382-91.
1997: Davis D A; Humphrey R W; Newcomb F M; O'Brien T R; Goedert J J; Straus S E; Yarchoan R
Detection of serum antibodies to a Kaposi's sarcoma-associated herpesvirus-specific peptide.
The Journal of infectious diseases 1997;175(5):1071-9.
1997: Sneller M C; Wang J; Dale J K; Strober W; Middelton L A; Choi Y; Fleisher T A; Lim M S; Jaffe E S; Puck J M; Lenardo M J; Straus S E
Clincal, immunologic, and genetic features of an autoimmune lymphoproliferative syndrome associated with abnormal lymphocyte apoptosis.
Blood 1997;89(4):1341-8.
1997: Williams R K; Straus S E
Specificity and affinity of binding of herpes simplex virus type 2 glycoprotein B to glycosaminoglycans.
Journal of virology 1997;71(2):1375-80.
1996: Straus S E; Rooney J F; Hallahan C
Acyclovir suppresses subclinical shedding of herpes simplex virus.
Annals of internal medicine 1996;125(9):776-7.
1996: Levine P H; Dale J K; Benson-Grigg E; Fritz S; Grufferman S; Straus S E
A cluster of cases of chronic fatigue and chronic fatigue syndrome: clinical and immunologic studies.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(2):408-9.
1996: Humphrey R W; O'Brien T R; Newcomb F M; Nishihara H; Wyvill K M; Ramos G A; Saville M W; Goedert J J; Straus S E; Yarchoan R
Kaposi's sarcoma (KS)-associated herpesvirus-like DNA sequences in peripheral blood mononuclear cells: association with KS and persistence in patients receiving anti-herpesvirus drugs.
Blood 1996;88(1):297-301.
1996: Kost R G; Straus S E
Postherpetic neuralgia--pathogenesis, treatment, and prevention.
The New England journal of medicine 1996;335(1):32-42.
1995: Meier J L; Straus S E
Interactions between varicella-zoster virus IE62 and cellular transcription factor USF in the coordinate activation of genes 28 and 29.
Neurology 1995;45(12 Suppl 8):S30-2.
1995: Straus S E
From molecular biology to medicine: two decades of achievement in varicella-zoster virus research.
Neurology 1995;45(12 Suppl 8):S11-2.
1995: Brown C R; Nakamura M S; Mosca J D; Hayward G S; Straus S E; Perera L P
Herpes simplex virus trans-regulatory protein ICP27 stabilizes and binds to 3' ends of labile mRNA.
Journal of virology 1995;69(11):7187-95.
1995: Moriuchi H; Moriuchi M; Pichyangkura R; Triezenberg S J; Straus S E; Cohen J I
Hydrophobic cluster analysis predicts an amino-terminal domain of varicella-zoster virus open reading frame 10 required for transcriptional activation.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(20):9333-7.
1995: Fisher G H; Rosenberg F J; Straus S E; Dale J K; Middleton L A; Lin A Y; Strober W; Lenardo M J; Puck J M
Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome.
Cell 1995;81(6):935-46.
1995: Kost R G; Kupinsky H; Straus S E
Varicella-zoster virus gene 63: transcript mapping and regulatory activity.
Virology 1995;209(1):218-24.
1995: Wang K; Krause P R; Straus S E
Analysis of the promoter and cis-acting elements regulating expression of herpes simplex virus type 2 latency-associated transcripts.
Journal of virology 1995;69(5):2873-80.
1995: Freifeld A G; Hilliard J; Southers J; Murray M; Savarese B; Schmitt J M; Straus S E
A controlled seroprevalence survey of primate handlers for evidence of asymptomatic herpes B virus infection.
The Journal of infectious diseases 1995;171(4):1031-4.
1995: McKenzie R; Straus S E
Chronic fatigue syndrome.
Advances in internal medicine 1995;40():119-53.
1994: Kennedy P G; Major E O; Williams R K; Straus S E
Down-regulation of glial fibrillary acidic protein expression during acute lytic varicella-zoster virus infection of cultured human astrocytes.
Virology 1994;205(2):558-62.
1994: Meier J L; Luo X; Sawadogo M; Straus S E
The cellular transcription factor USF cooperates with varicella-zoster virus immediate-early protein 62 to symmetrically activate a bidirectional viral promoter.
Molecular and cellular biology 1994;14(10):6896-906.
1994: Straus S E; Komaroff A L; Wedner H J
Chronic fatigue syndrome: point and counterpoint.
The Journal of infectious diseases 1994;170(1):1-6.
1994: Straus S E; Corey L; Burke R L; Savarese B; Barnum G; Krause P R; Kost R G; Meier J L; Sekulovich R; Adair S F
Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes.
Lancet 1994;343(8911):1460-3.
1994: Perera L P; Kaushal S; Kinchington P R; Mosca J D; Hayward G S; Straus S E
Varicella-zoster virus open reading frame 4 encodes a transcriptional activator that is functionally distinct from that of herpes simplex virus homology ICP27.
Journal of virology 1994;68(4):2468-77.
1994: Goins W F; Sternberg L R; Croen K D; Krause P R; Hendricks R L; Fink D J; Straus S E; Levine M; Glorioso J C
A novel latency-active promoter is contained within the herpes simplex virus type 1 UL flanking repeats.
Journal of virology 1994;68(4):2239-52.
1994: Moriuchi M; Moriuchi H; Straus S E; Cohen J I
Varicella-zoster virus (VZV) virion-associated transactivator open reading frame 62 protein enhances the infectivity of VZV DNA.
Virology 1994;200(1):297-300.
1994: Straus S E
Overview: the biology of varicella-zoster virus infection.
Annals of neurology 1994;35 Suppl():S4-8.
1993: Kost R G; Hill E L; Tigges M; Straus S E
Brief report: recurrent acyclovir-resistant genital herpes in an immunocompetent patient.
The New England journal of medicine 1993;329(24):1777-82.
1993: Meier J L; Straus S E
Varicella-zoster virus DNA polymerase and major DNA-binding protein genes have overlapping divergent promoters.
Journal of virology 1993;67(12):7573-81.
1993: Perera L P; Mosca J D; Ruyechan W T; Hayward G S; Straus S E; Hay J
A major transactivator of varicella-zoster virus, the immediate-early protein IE62, contains a potent N-terminal activation domain.
Journal of virology 1993;67(8):4474-83.
1993: Moriuchi H; Moriuchi M; Straus S E; Cohen J I
Varicella-zoster virus (VZV) open reading frame 61 protein transactivates VZV gene promoters and enhances the infectivity of VZV DNA.
Journal of virology 1993;67(7):4290-5.
1993: Straus S E; Savarese B; Tigges M; Freifeld A G; Krause P R; Margolis D M; Meier J L; Paar D P; Adair S F; Dina D
Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine.
The Journal of infectious diseases 1993;167(5):1045-52.
1993: Moriuchi H; Moriuchi M; Straus S E; Cohen J I
Varicella-zoster virus open reading frame 10 protein, the herpes simplex virus VP16 homolog, transactivates herpesvirus immediate-early gene promoters.
Journal of virology 1993;67(5):2739-46.
1993: Straus S E
Shingles. Sorrows, salves, and solutions.
JAMA : the journal of the American Medical Association 1993;269(14):1836-9.
1993: Meier J L; Holman R P; Croen K D; Smialek J E; Straus S E
Varicella-zoster virus transcription in human trigeminal ganglia.
Virology 1993;193(1):193-200.
1993: Laycock K A; Lee S F; Stulting R D; Croen K D; Ostrove J M; Straus S E; Pepose J S
Herpes simplex virus type 1 transcription is not detectable in quiescent human stromal keratitis by in situ hybridization.
Investigative ophthalmology & visual science 1993;34(2):285-92.
1993: Rooney J F; Straus S E; Mannix M L; Wohlenberg C R; Alling D W; Dumois J A; Notkins A L
Oral acyclovir to suppress frequently recurrent herpes labialis. A double-blind, placebo-controlled trial.
Annals of internal medicine 1993;118(4):268-72.
1993: Straus S E; Fritz S; Dale J K; Gould B; Strober W
Lymphocyte phenotype and function in the chronic fatigue syndrome.
Journal of clinical immunology 1993;13(1):30-40.
1993: Straus S E
Studies of herpesvirus infection in chronic fatigue syndrome.
Ciba Foundation symposium 1993;173():132-9; discussion 139-45.
1992: Moriuchi H; Moriuchi M; Smith H A; Straus S E; Cohen J I
Varicella-zoster virus open reading frame 61 protein is functionally homologous to herpes simplex virus type 1 ICP0.
Journal of virology 1992;66(12):7303-8.
1992: Rooney J F; Straus S E; Mannix M L; Wohlenberg C R; Banks S; Jagannath S; Brauer J E; Notkins A L
UV light-induced reactivation of herpes simplex virus type 2 and prevention by acyclovir.
The Journal of infectious diseases 1992;166(3):500-6.
1992: Sneller M C; Straus S E; Jaffe E S; Jaffe J S; Fleisher T A; Stetler-Stevenson M; Strober W
A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease.
The Journal of clinical investigation 1992;90(2):334-41.
1992: Meier J L; Straus S E
Comparative biology of latent varicella-zoster virus and herpes simplex virus infections.
The Journal of infectious diseases 1992;166 Suppl 1():S13-23.
1992: Dale J K; Straus S E
The chronic fatigue syndrome: considerations relevant to children and adolescents.
Advances in pediatric infectious diseases 1992;7():63-83.
1992: Straus S E
Acute progressive Epstein-Barr virus infections.
Annual review of medicine 1992;43():437-49.
1991: Rooney J F; Bryson Y; Mannix M L; Dillon M; Wohlenberg C R; Banks S; Wallington C J; Notkins A L; Straus S E
Prevention of ultraviolet-light-induced herpes labialis by sunscreen.
Lancet 1991;338(8780):1419-22.
1991: Krause P R; Ostrove J M; Straus S E
The nucleotide sequence, 5' end, promoter domain, and kinetics of expression of the gene encoding the herpes simplex virus type 2 latency-associated transcript.
Journal of virology 1991;65(10):5619-23.
1991: Dale J K; Di Bisceglie A M; Hoofnagle J H; Straus S E
Chronic fatigue syndrome: lack of association with hepatitis C virus infection.
Journal of medical virology 1991;34(2):119-21.
1991: Straus S E
History of chronic fatigue syndrome.
Reviews of infectious diseases 1991;13 Suppl 1():S2-7.
1991: Croen K D; Ostrove J M; Dragovic L; Straus S E
Characterization of herpes simplex virus type 2 latency-associated transcription in human sacral ganglia and in cell culture.
The Journal of infectious diseases 1991;163(1):23-8.
1990: Krause P R; Straus S E
Zoster and its complications.
Hospital practice (Office ed.) 1990;25(10A):61-71, 75-6.
1990: Krause P R; Croen K D; Ostrove J M; Straus S E
Structural and kinetic analyses of herpes simplex virus type 1 latency-associated transcripts in human trigeminal ganglia and in cell culture.
The Journal of clinical investigation 1990;86(1):235-41.
1990: Abbondanzo S L; Sato N; Straus S E; Jaffe E S
Acute infectious mononucleosis. CD30 (Ki-1) antigen expression and histologic correlations.
American journal of clinical pathology 1990;93(5):698-702.
1989: Straus S E
Clinical and biological differences between recurrent herpes simplex virus and varicella-zoster virus infections.
JAMA : the journal of the American Medical Association 1989;262(24):3455-8.
1989: Levine P H; Krueger G R; Straus S E
A postviral chronic fatigue syndrome: a round table.
The Journal of infectious diseases 1989;160(4):722-4.
1989: Straus S E; Seidlin M; Takiff H E; Rooney J F; Felser J M; Smith H A; Roane P; Johnson F; Hallahan C; Ostrove J M
Effect of oral acyclovir treatment on symptomatic and asymptomatic virus shedding in recurrent genital herpes.
Sexually transmitted diseases 1989;16(2):107-13.
1988: Straus S E; Dale J K; Tobi M; Lawley T; Preble O; Blaese R M; Hallahan C; Henle W
Acyclovir treatment of the chronic fatigue syndrome. Lack of efficacy in a placebo-controlled trial.
The New England journal of medicine 1988;319(26):1692-8.
1988: Croen K D; Ostrove J M; Dragovic L J; Straus S E
Patterns of gene expression and sites of latency in human nerve ganglia are different for varicella-zoster and herpes simplex viruses.
Proceedings of the National Academy of Sciences of the United States of America 1988;85(24):9773-7.
1988: Krause P R; Croen K D; Straus S E; Ostrove J M
Detection and preliminary characterization of herpes simplex virus type 1 transcripts in latently infected human trigeminal ganglia.
Journal of virology 1988;62(12):4819-23.
1988: Baranski B; Armstrong G; Truman J T; Quinnan G V; Straus S E; Young N S
Epstein-Barr virus in the bone marrow of patients with aplastic anemia.
Annals of internal medicine 1988;109(9):695-704.
1988: Straus S E; Croen K D; Sawyer M H; Freifeld A G; Felser J M; Dale J K; Smith H A; Hallahan C; Lehrman S N
Acyclovir suppression of frequently recurring genital herpes. Efficacy and diminishing need during successive years of treatment.
JAMA : the journal of the American Medical Association 1988;260(15):2227-30.
1988: Sawyer M H; Inchauspe G; Biron K K; Waters D J; Straus S E; Ostrove J M
Molecular analysis of the pyrimidine deoxyribonucleoside kinase gene of wild-type and acyclovir-resistant strains of varicella-zoster virus.
The Journal of general virology 1988;69 ( Pt 10)():2585-93.
1988: Straus S E
Treatment of persistent active herpesvirus infections.
Journal of virological methods 1988;21(1-4):305-13.
1988: Sawyer M H; Webb D E; Balow J E; Straus S E
Acyclovir-induced renal failure. Clinical course and histology.
The American journal of medicine 1988;84(6):1067-71.
1988: Felser J M; Kinchington P R; Inchauspe G; Straus S E; Ostrove J M
Cell lines containing varicella-zoster virus open reading frame 62 and expressing the "IE" 175 protein complement ICP4 mutants of herpes simplex virus type 1.
Journal of virology 1988;62(6):2076-82.
1988: Straus S E; Dale J K; Wright R; Metcalfe D D
Allergy and the chronic fatigue syndrome.
The Journal of allergy and clinical immunology 1988;81(5 Pt 1):791-5.
1988: Straus S E
The chronic mononucleosis syndrome.
The Journal of infectious diseases 1988;157(3):405-12.
1988: Reinhold W C; Straus S E; Ostrove J M
Directionality and further mapping of varicella zoster virus transcripts.
Virus research 1988;9(2-3):249-61.
1988: Straus S E; Ostrove J M; Inchauspé G; Felser J M; Freifeld A; Croen K D; Sawyer M H
NIH conference. Varicella-zoster virus infections. Biology, natural history, treatment, and prevention.
Annals of internal medicine 1988;108(2):221-37.
1987: Croen K D; Ostrove J M; Dragovic L J; Smialek J E; Straus S E
Latent herpes simplex virus in human trigeminal ganglia. Detection of an immediate early gene "anti-sense" transcript by in situ hybridization.
The New England journal of medicine 1987;317(23):1427-32.
1987: Perna J J; Mannix M L; Rooney J F; Notkins A L; Straus S E
Reactivation of latent herpes simplex virus infection by ultraviolet light: a human model.
Journal of the American Academy of Dermatology 1987;17(3):473-8.
1987: Ellis M N; Keller P M; Fyfe J A; Martin J L; Rooney J F; Straus S E; Lehrman S N; Barry D W
Clinical isolate of herpes simplex virus type 2 that induces a thymidine kinase with altered substrate specificity.
Antimicrobial agents and chemotherapy 1987;31(7):1117-25.
1987: Straus S E
The management of varicella and zoster infections.
Infectious disease clinics of North America 1987;1(2):367-82.
1987: Felser J M; Straus S E; Ostrove J M
Varicella-zoster virus complements herpes simplex virus type 1 temperature-sensitive mutants.
Journal of virology 1987;61(1):225-8.
1986: Lehrman S N; Hill E L; Rooney J F; Ellis M N; Barry D W; Straus S E
Extended acyclovir therapy for herpes genitalis: changes in virus sensitivity and strain variation.
The Journal of antimicrobial chemotherapy 1986;18 Suppl B():85-94.
1986: Kinchington P R; Remenick J; Ostrove J M; Straus S E; Ruyechan W T; Hay J
Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.
Journal of virology 1986;59(3):660-8.
1986: Rooney J F; Felser J M; Ostrove J M; Straus S E
Acquisition of genital herpes from an asymptomatic sexual partner.
The New England journal of medicine 1986;314(24):1561-4.
1986: Straus S E; Seidlin M; Takiff H E; Rooney J F; Lehrman S N; Bachrach S; Felser J M; Di Giovanna J J; Grimes G J; Krakauer H
Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes.
Antiviral research 1986;6(3):151-9.
1986: Ryder J W; Croen K; Kleinschmidt-DeMasters B K; Ostrove J M; Straus S E; Cohn D L
Progressive encephalitis three months after resolution of cutaneous zoster in a patient with AIDS.
Annals of neurology 1986;19(2):182-8.
1986: Sawyer M H; Ostrove J M; Felser J M; Straus S E
Mapping of the varicella zoster virus deoxypyrimidine kinase gene and preliminary identification of its transcript.
Virology 1986;149(1):1-9.
1985: Kinchington P R; Reinhold W C; Casey T A; Straus S E; Hay J; Ruyechan W T
Inversion and circularization of the varicella-zoster virus genome.
Journal of virology 1985;56(1):194-200.
1985: Straus S E; Rooney J F; Sever J L; Seidlin M; Nusinoff-Lehrman S; Cremer K
NIH Conference. Herpes simplex virus infection: biology, treatment, and prevention.
Annals of internal medicine 1985;103(3):404-19.
1985: Takiff H E; Seidlin M; Krause P; Rooney J; Brandt C; Rodriguez W; Yolken R; Straus S E
Detection of enteric adenoviruses by dot-blot hybridization using a molecularly cloned viral DNA probe.
Journal of medical virology 1985;16(2):107-18.
1985: Casey T A; Ruyechan W T; Flora M N; Reinhold W; Straus S E; Hay J
Fine mapping and sequencing of a variable segment in the inverted repeat region of varicella-zoster virus DNA.
Journal of virology 1985;54(2):639-42.
1985: Felser J M; Croen K D; Sawyer M H; Rooney J F; Ostrove J M; Straus S E
Does idoxuridine help herpes labialis?
The New England journal of medicine 1985;312(13):859.
1985: Ruyechan W T; Casey T A; Reinhold W; Weir A C; Wellman M; Straus S E; Hay J
Distribution of G + C-rich regions in varicella-zoster virus DNA.
The Journal of general virology 1985;66 ( Pt 1)():43-54.
1984: Straus S E; Reinhold W; Smith H A; Ruyechan W T; Henderson D K; Blaese R M; Hay J
Endonuclease analysis of viral DNA from varicella and subsequent zoster infections in the same patient.
The New England journal of medicine 1984;311(21):1362-4.
1984: Straus S E; Takiff H E; Seidlin M; Bachrach S; Lininger L; DiGiovanna J J; Western K A; Smith H A; Lehrman S N; Creagh-Kirk T
Suppression of frequently recurring genital herpes. A placebo-controlled double-blind trial of oral acyclovir.
The New England journal of medicine 1984;310(24):1545-50.
1984: Straus S E; Seidlin M; Takiff H
Management of mucocutaneous herpes simplex virus infections.
Drugs 1984;27(4):364-72.
1984: Straus S E; Seidlin M; Takiff H; Jacobs D; Bowen D; Smith H A
Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients.
Annals of internal medicine 1984;100(4):522-4.
1984: Seidlin M; Takiff H E; Smith H A; Hay J; Straus S E
Detection of varicella-zoster virus by dot-blot hybridization using a molecularly cloned viral DNA probe.
Journal of medical virology 1984;13(1):53-61.
1983: Straus S E; Seidlin M; Takiff H E; Bachrach S; DiGiovanna J J; Western K A; Creagh-Kirk T; Lininger L; Alling D W
Suppression of recurrent genital herpes with oral acyclovir.
Transactions of the Association of American Physicians 1983;96():278-83.

Sign-in to see more